Puna Bio

Puna’s microbial seed treatments are intended to help crops acquire nutrients and tolerate environmental stress, potentially maintaining yield with less synthetic fertilizer or on land with degraded soils. Biological nitrogen fixation and improved nutrient-use efficiency could reduce input costs and upstream fertilizer emissions. Seed treatment also uses small product volumes and can fit existing planting workflows.

Benefits are not automatic. Microbial performance is highly dependent on strain, crop, soil community, weather, formulation, storage, and farm practice. Yield gains in selected trials may not reproduce across regions, and restoring soil function is broader than increasing one season’s harvest. Puna has not published a company-wide lifecycle assessment, verified fertilizer-displacement total, or long-term soil-carbon result.

Puna reports more than 35 international testing sites and field trials across multiple crops and environments. Company and investor materials have cited yield gains reaching approximately 15%–20% in selected soybean and wheat trials under stress. These are attributed trial results, not guaranteed commercial performance, and public summaries do not provide enough protocol and site-level data for a pooled independent estimate.

Kanzama and Kunza are commercial seed-treatment inoculants in specified markets, while Tayrix’s status must be checked against each national registration before sale or agronomic recommendation. Partnerships supporting testing in Africa and the United States represent planned validation and market development, not hectares treated or food produced.

Puna announced a $3.7 million seed round in 2023 and an undisclosed Series A in 2025 that included Corteva Catalyst and Gates Foundation participation. Funding, awards, strain-library size, and test-site counts measure organizational progress; they do not quantify avoided emissions, restored soil, or farmer income.